The ProSPoNS Trial: Statistical Analysis Protocol for Evaluating Efficacy of Probiotic Supplementation for Prevention of Neonatal Sepsis in 0–2-month-old Low Birth Weight Infants in India

Introduction: A Phase III multicentre randomised, double-blind, placebo-controlled trial evaluating the role of probiotics in the prevention of neonatal sepsis in 0–2-month-old Indian infants was conducted at six study sites in India, funded by UKRI-MRC and coordinated by ICMR. Methods and Analysis:...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Dilip Raja, Kamaleshwar S Mahajan, Anju P Sinha, Subodh S. Gupta, Ramesh Poluru, Rishikesh Sudhakar, Abhishek V. Raut, Bethou Adhisivam, Anand S Kawade, Arti Kapil, Ashish Bavdekar, Girish Dayma, Mohd Azam, Prabhabati Devi, Rajini Gaind, Rashmita B Nayak, Sailajanand Parida, Sunil Sazawal, Sushma Nangia, Tharikka Fathima, Ravindra Mohan Pandey, Narendra K Arora, ProSPoNS Study Group
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Wolters Kluwer Medknow Publications 2026-01-01
Sarja:	Preventive Medicine: Research & Reviews
Aiheet:	itt neonatal clinical trial phase-iii neonatal clinical trial pp probiotics prospons trial possible serious bacterial infection sepsis
Linkit:	https://journals.lww.com/10.4103/PMRR.PMRR_121_25
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!